News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Tom Powles: New ESMO’s guidlines for advanced bladder cancer Annals of Oncology – Enforumab Vedotin and pembrolizumab is the new standard of care
Photo from Tom Powles/Twitter
Mar 17, 2024, 19:51

Tom Powles: New ESMO’s guidlines for advanced bladder cancer Annals of Oncology – Enforumab Vedotin and pembrolizumab is the new standard of care

Tom Powles, Director of Barts Cancer Center, shared a post on X:

“New ESMO’s guidelines for advanced bladder cancer Annals of Oncology. Enforumab Vedotin and pembrolizumab is the new standard of care. Platinum therapy is now 2nd line and eligibility less relevant.”

Tom Powles: New ESMO's guidlines for advanced bladder cancer Annals of Oncology - Enforumab Vedotin and pembrolizumab is the new standard of care   Tom Powles: New ESMO's guidlines for advanced bladder cancer Annals of Oncology - Enforumab Vedotin and pembrolizumab is the new standard of care

View the article.
Source: Tom Powles/X

Annals of Oncology Barts Cancer Center bladder cancer cancer Enforumab Vedotin ESMO OncoDaily Oncology pembrolizumab Platinum therapy Tom Powles
Special Coverage
Blog
Apr 21, 2025, 16:25
Eugene A. Woods: Happy Valley shaped my story
Blog
Apr 21, 2025, 16:15
Paolo Tarantino: T-DXd with Pertuzumab improves PFS vs THP in first-line HER2+ mBC
Insight
Apr 21, 2025, 16:13
ESMO Highlights Resilience and Burnout Prevention in Oncology
Blog
Apr 21, 2025, 16:05
The Conquest of Cancer and the Next Generation of Cancer Researchers - AACR
Blog
Apr 21, 2025, 15:54
Patricia Spears will chair the AACR25 Patient Advocate Poster Symposium
Blog
Apr 21, 2025, 15:52
Mohamed Ghazi: From the official opening to becoming the largest specialized breast care center in the UAE
Science
Apr 21, 2025, 15:43
Sean Pitroda: Facts and hopes in radioimmunotherapy of oligometastatic disease
Science
Apr 21, 2025, 15:28
Deepak Gupta: New Organ at Risk for SBRT coming soon
Blog
Apr 21, 2025, 15:20
Exploring physical activity interventions in childhood cancer - a SIOP Nutrition Network webinar
Blog
Apr 21, 2025, 15:06
Lisa Larkin: HERtalks - a new virtual series bringing clear, evidence-based info to women
Blog
Apr 21, 2025, 14:57
Douglas Flora: Unveiling a new era of AI in Precision Oncology
Insight
Apr 21, 2025, 14:55
Living with Type 2 diabetes have a significantly higher risk of developing liver and pancreatic cancers - Manchester Cancer Research Centre